Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: A coordinated approach
Fredrik Nyberg, Johan Askling, Niklas Berglind, Stefan Franzén, Meilien Ho, Marie Holmqvist, Laura Horne, Kathy Lampl, Kaleb Michaud, Dimitrios A. Pappas, George Reed, Deborah Symmons, Eiichi Tanaka, Trung N. Tran, Suzanne M.M. Verstappen, Eveline Wesby-van Swaay, Hisashi Yamanaka, Jeffrey D. Greenberg
Dive into the research topics of 'Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: A coordinated approach'. Together they form a unique fingerprint.